About Siren
Siren is a company based in San Francisco (United States) founded in 2015 by Henk Jan Scholten, Jie Fu, and Ran Ma. It operates as a HealthTech and Product-as-a-Service. Siren has raised $40.38 million across 13 funding rounds from investors including Khosla Ventures, Molnlycke Health Care and Aging2.0. Siren offers products and services including Siren Socks. Siren operates in a competitive market with competitors including Orpyx, Reapplix, PulseFlow, Mynerva and MR3Health, among others.
- Headquarter San Francisco, United States
- Founders Henk Jan Scholten, Jie Fu, Ran Ma
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Siren Care Denmark Ivs
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$40.38 M (USD)
in 13 rounds
-
Latest Funding Round
$9.5 M (USD), Series B
Jan 08, 2025
-
Investors
Khosla Ventures
& 14 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Siren
Siren offers a comprehensive portfolio of products and services, including Siren Socks.
Foot temperature is monitored to prevent diabetic ulcers.
People of Siren
Unlock access to complete
Unlock access to complete
Funding Insights of Siren
Siren has successfully raised a total of $40.38M across 13 strategic funding rounds. The most recent funding activity was a Series B round of $9.5 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Siren
Siren has secured backing from 15 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Khosla Ventures, Molnlycke Health Care and Aging2.0.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage ventures are targeted for investment by this VC fund.
|
Locked | Locked | Locked | |
|
Venture capital funding is provided by Mighty Capital to innovators.
|
Locked | Locked | Locked | |
|
Venture capital firm creating funds for innovative companies in women's health and emerging markets.
|
Locked | Locked | Locked |
Investor details for Siren
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Siren
Investment portfolio details for Siren
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Siren
Detailed financials for Siren
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Siren Comparisons
Peer comparison for Siren
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Siren
Siren operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orpyx, Reapplix, PulseFlow, Mynerva and MR3Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable sensor insoles are developed for neuropathy and athletic monitoring.
|
|
| Locked | Locked | Locked |
Developer of patch system for wound healing
|
|
| Locked | Locked | Locked |
Diabetic foot ulcers are treated with a boot-shaped compression device.
|
|
| Locked | Locked | Locked |
An AI-supported neurostimulating device is provided for diabetic neuropathy treatment.
|
|
| Locked | Locked | Locked |
Provider of monitoring services to health insurers for diabetic neuropathy patients
|
Detailed competitors of Siren
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Siren
Complete news archive for Siren
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Siren
Siren was founded in 2015.
Siren is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Ran Ma is the current CEO of Siren. They have also founded this company.
Siren is a funded company, having raised a total of $40.38M across 13 funding rounds to date.
Foot care technology is developed by Siren to prevent diabetic foot ulcers. Temperature monitoring through wearable socks is utilized to detect early signs of inflammation and injury. Support is offered to patients, providers, and payers with continuous monitoring by licensed nurses. The healthcare sector is primarily served, focusing on diabetes management solutions.
Siren offers Siren Socks.
Siren has 15 investors. Key investors include Khosla Ventures, Molnlycke Health Care, Aging2.0, Manta Ray, and Mighty Capital.